Xi Dan, Bao Ting, Chen Qi, Chen Sushing, Cheng Yung-Chi, Cullen Joseph, Frank David A, Friedberg Jonathan W, Kronish Ian, Lee Jeffrey E, Levine Mark, Li Pingping, Li Shao, Lu Weidong, Mao Jun J, O'Keefe Stephen, Rubinstein Larry, Shah Manish A, Standish Leanna, Paller Channing J, Chu Edward
Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville, MD; National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD; Memorial Sloan Kettering Cancer Center, New York, NY; University of Kansas, Lawrence, KS; University of Florida, Gainsville, FL; Yale University, New Haven, CT; University of Iowa, Iowa City, IA; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; University of Rochester Medical Center, Rochester, NY; Columbia University Medical Center, New York, NY; The University of Texas MD Anderson Cancer Center, Houston, TX; Peking University Cancer Hospital, Beijing, China; University of Pittsburgh, Pittsburgh, PA; Weill Cornell Medicine at Cornell University, New York, NY; Bastyr University, Kenmore, WA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University, Baltimore, MD; Tsinghua University, Beijing, China.
J Natl Cancer Inst Monogr. 2017 Nov 1;2017(52). doi: 10.1093/jncimonographs/lgx003.
In May 2016, the Office of Cancer Complementary and Alternative Medicine, Division of Cancer Diagnosis and Treatment, of the National Cancer Institute convened a special workshop focused on the State of the Science: Cancer Complementary and Alternative Medicine Therapeutics Research. The current state of the science, gaps, and future opportunities were reviewed and discussed by a distinguished panel of experts in this field of research, and the highlights of this meeting are reported herein.
2016年5月,美国国立癌症研究所癌症诊断与治疗司癌症补充与替代医学办公室召开了一次特别研讨会,重点关注科学现状:癌症补充与替代医学治疗研究。该领域的杰出专家小组对当前的科学现状、差距和未来机遇进行了回顾和讨论,本文报告了此次会议的要点。